You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 17, 2024

Investigational Drug Information for PF-06826647

✉ Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug PF-06826647?

PF-06826647 is an investigational drug.

There have been 6 clinical trials for PF-06826647. The most recent clinical trial was a Phase 2 trial, which was initiated on December 2nd 2019.

The most common disease conditions in clinical trials are Psoriasis, Hidradenitis, and Ulcer. The leading clinical trial sponsors are Pfizer and [disabled in preview].

There are two US patents protecting this investigational drug and fifty-one international patents.

Recent Clinical Trials for PF-06826647
A Study To Asses Mass Balance And Absolute Bioavailability Of 14C PF-06826647 In Healthy Male ParticipantsPfizerPhase 1
A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative ColitisPfizerPhase 2
A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis SuppurativaPfizerPhase 2

See all PF-06826647 clinical trials

Clinical Trial Summary for PF-06826647

Top disease conditions for PF-06826647
Top clinical trial sponsors for PF-06826647

See all PF-06826647 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.